相关实验视频

Updated: May 3, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

超声波刺激通过调节前额叶皮层中多巴胺释放来减轻CRS诱导的抑郁行为

Ling Wang, Sutong Wang, Weiyi Mo

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society

|March 18, 2024

概括

针对腹膜区域 (VTA) 的聚焦超声波刺激 (FUS) 有效地减少了老鼠的类似抑郁症的行为. 这种神经调节方法还恢复了中间前额叶皮质 (mPFC) 中的多巴胺水平.

科学领域:

神经科学是一个神经科学.
神经调节是一种神经调节.
精神病学是一个精神病学.

背景情况:

抑郁症是一种严重的精神障碍,通常与慢性压力和多巴胺系统功能障碍有关.
腹膜区域 (VTA) 富含多巴胺基神经元,与与压力相关的情绪障碍有关.
聚焦超声波刺激 (FUS) 是一种新兴的神经调节技术,具有潜在的治疗应用.

研究的目的:

研究VTA向FUS在缓解慢性压力诱导抑郁行为的有效性.
评估FUS对中部前额叶皮层 (mPFC) 多巴胺水平的影响.
为了确定FUS是否保护VTA多巴胺基神经元免受慢性压力损伤.

主要方法:

慢性克制压力 (CRS) 用于在动物模型中诱导类似抑郁症的行为.
集中式超声波刺激 (FUS) 针对VTA进行了应用.
在体内测光仪被用来测量mPFC中的多巴胺水平.
行为测试评估了无情和绝望.

主要成果:

针对VTA的FUS显著缓解了CRS诱导的无情和绝望行为.
FUS治疗导致mPFC多巴胺水平显著增加,与行为改善相关.
FUS保护了VTA中的多巴胺基神经元免受CRS诱导的损伤.

结论:

用FUS对静脉动脉进行向是缓解与压力相关的抑郁行为的一个有希望的策略.
FUS增强了mPFC中的多巴胺信号传递,并保护了VTA的多巴胺神经元.
FUS代表了与压力相关的情绪障碍的潜在新型治疗方法.

更多相关视频

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

相关概念视频

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...